Emphysema Market Research Report - Forecast to 2027

Emphysema Market Research Report: By Type (Centrilobular, Panlobular), By Diagnosis (Imaging Test (X-Ray, Ct Scan), Lung Function Test), by Treatment (Medication (Antibiotics, Bronchodilators), Therapy, Surgery), by End-User-Global Forecast till 2027

ID: MRFR/Pharma/4354-HCR | February 2021 | Region: Global | 100 Pages         

Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Emphysema Market, by Type

6.1 Introduction

6.2 Centrilobular

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 Panlobular

6.3.1 Market Estimates & Forecast, 2020-2027

7. Global Emphysema Market, by Diagnosis

7.1 Introduction

7.2 Imaging Test

7.2.1 Market Estimates & Forecast, 2020–2027

7.3 Lung Function Test

7.3.1 Market Estimates & Forecast, 2020–2027

7.4 Others

7.4.1 Market Estimates & Forecast, 2020–2027

8. Global Emphysema Market, by Treatment

8.1 Introduction

8.2 Medication

8.2.1 Market Estimates & Forecast, 2020–2027

8.3 Therapy

8.3.1 Market Estimates & Forecast, 2020–2027

8.4 Surgery

8.4.1 Market Estimates & Forecast, 2020–2027

9. Global Emphysema Market, by End-User

9.1 Introduction

9.2 Hospitals & Clinics

9.2.1 Market Estimates & Forecast, 2020–2027

9.3 Surgical Center

9.3.1 Market Estimates & Forecast, 2020–2027

9.4 Others

9.4.1 Market Estimates & Forecast, 2020–2027

10. Global Emphysema Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.1 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 UK

10.3.1.4 Italy

10.3.1.5 Spain

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12 Company Profiles

12.1 Intrexon Corporation

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 Pulmonx Inc.

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Bioxyne Limited

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 PneumRx

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Uptake Medical Corporation

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 Icure Pharmaceuticals, Inc.

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 Pfizer, Inc.

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Others

13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Diagnostic Tests Industry

14 Appendix

LIST OF TABLES

Table 1 Emphysema Industry Synopsis, 2020-2027

Table 2 Global Emphysema Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Global Emphysema Market by Region, 2020-2027, (USD Million)

Table 4 Global Emphysema Market by Types, 2020-2027, (USD Million)

Table 5 Global Emphysema Market by Diagnosis, 2020-2027, (USD Million)

Table 6 Global Emphysema Market by Treatment, 2020-2027, (USD Million)

Table 7 Global Emphysema Market by End Users, 2020-2027, (USD Million)

Table 8 North America Emphysema Market by Types, 2020-2027, (USD Million)

Table 9 North America Emphysema Market by Diagnosis, 2020-2027, (USD Million)

Table 10 North America Emphysema Market by Treatment, 2020-2027, (USD Million)

Table 11 North America Emphysema Market by End Users, 2020-2027, (USD Million)

Table 12 US Emphysema Market by Types, 2020-2027, (USD Million)

Table 13 US Emphysema Market by Diagnosis, 2020-2027, (USD Million)

Table 14 US Emphysema Market by Treatment, 2020-2027, (USD Million)

Table 15 US Emphysema Market by End Users, 2020-2027, (USD Million)

Table 16 Canada Emphysema Market by Types, 2020-2027, (USD Million)

Table 17 Canada Emphysema Market by Diagnosis, 2020-2027, (USD Million)

Table 18 Canada Emphysema Market by Treatment, 2020-2027, (USD Million)

Table 19 Canada Emphysema Market by End Users, 2020-2027, (USD Million)

Table 20 South America Emphysema Market by Types, 2020-2027, (USD Million)

Table 21 South America Emphysema Market by Diagnosis, 2020-2027, (USD Million)

Table 22 South America Emphysema Market by Treatment, 2020-2027, (USD Million)

Table 23 South America Emphysema Market by End Users, 2020-2027, (USD Million)

Table 24 Europe Emphysema Market by Types, 2020-2027, (USD Million)

Table 25 Europe Emphysema Market by Diagnosis, 2020-2027, (USD Million)

Table 26 Europe Emphysema Market by Treatment, 2020-2027, (USD Million)

Table 27 Europe Emphysema Market by End Users, 2020-2027, (USD Million)

Table 28 Western Europe Emphysema Market by Types, 2020-2027, (USD Million)

Table 29 Western Europe Emphysema Market by Diagnosis, 2020-2027, (USD Million)

Table 30 Western Europe Emphysema Market by Treatment, 2020-2027, (USD Million)

Table 31 Western Europe Emphysema Market by End Users, 2020-2027, (USD Million)

Table 32 Eastern Europe Emphysema Market by Types, 2020-2027, (USD Million)

Table 33 Eastern Europe Emphysema Market by Diagnosis, 2020-2027, (USD Million)

Table 34 Eastern Europe Emphysema Market by Treatment, 2020-2027, (USD Million)

Table 35 Eastern Europe Emphysema Market by End Users, 2020-2027, (USD Million)

Table 36 Asia Pacific Emphysema Market by Types, 2020-2027, (USD Million)

Table 37 Asia Pacific Emphysema Market by Diagnosis, 2020-2027, (USD Million)

Table 38 Asia Pacific Emphysema Market by Treatment, 2020-2027, (USD Million)

Table 39 Asia Pacific Emphysema Market by End Users, 2020-2027, (USD Million)

Table 40 Middle East & Africa Emphysema Market by Types, 2020-2027, (USD Million)

Table 41 Middle East & Africa Emphysema Market by Diagnosis, 2020-2027, (USD Million)

Table 42 Middle East & Africa Emphysema Market by Treatment, 2020-2027, (USD Million)

Table 43 Middle East & Africa Emphysema Market by End Users, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Emphysema Market

Figure 3 Segmentation Market Dynamics for Emphysema Market

Figure 4 Global Emphysema Market Share, by Diagnosis 2020

Figure 5 Global Emphysema Market Share, by Treatment 2020

Figure 6 Global Emphysema Market Share, by End Users, 2020

Figure 7 Global Emphysema Market Share, by Region, 2020

Figure 8 North America Emphysema Market Share, by Country, 2020

Figure 9 Europe Emphysema Market Share, by Country, 2020

Figure 10 Asia Pacific Emphysema Market Share, by Country, 2020

Figure 11 Middle East & Africa Emphysema Market Share, by Country, 2020

Figure 12 Global Emphysema Market: Company Share Analysis, 2020 (%)

Figure 13 Intrexon Corporation: Key Financials

Figure 14 Intrexon Corporation: Segmental Revenue

Figure 16 Intrexon Corporation: Geographical Revenue

Figure 17 Pulmonx Inc.: Key Financials

Figure 18 Pulmonx Inc.: Segmental Revenue

Figure 19 Pulmonx Inc.: Geographical Revenue

Figure 20 Uptake Medical Corporation: Key Financials

Figure 21 Uptake Medical Corporation: Segmental Revenue

Figure 22 Uptake Medical Corporation: Geographical Revenue

Figure 23 PNEUMRX: Key Financials

Figure 24 PNEUMRX: Segmental Revenue

Figure 25 PNEUMRX: Geographical Revenue

Figure 26 Olympus Corporation: Segmental Revenue

Figure 27 Olympus Corporation: Geographical Revenue

Figure 28 Olympus Corporation: Key Financials

Figure 29 Icure Pharmaceuticals, Inc.: Segmental Revenue

Figure 30 Icure Pharmaceuticals, Inc.: Geographical Revenue

Figure 31 Icure Pharmaceuticals, Inc: Key Financials

Market Synopsis


Emphysema, a lung disease is characterized by the shortness of breath, thereby, damaging the air sacs in the lungs. The disease leads to rupture and weakening of inner walls of the air sacs over the period. The disease involves the reduction in the surface area of the lungs which in turn reduces the amount of oxygen reaching the bloodstream. Hence, during exhalation, the alveoli do not function properly leaving the air trapped in the lungs, leaving no space for oxygen-rich air to enter the lungs. Emphysema and chronic bronchitis are together known as the Chronic Obstructive Pulmonary Disease (COPD). The patients suffering from emphysema also have chronic bronchitis. The major causes of emphysema are exposure to air pollutants, chemical fumes, and dust and smoking. The condition can be diagnosed through various tests such as imaging tests that include chest X-ray and CT scan and the lung function test.


The global emphysema market is mainly driven by the high prevalence of respiratory diseases such as chronic bronchitis, emphysema, and others and a huge demand for treatment including smoking cessation drugs and antibiotics. Additionally, the rising availability of diagnostic services for respiratory illness also fuels the growth of the market.


According to the World Health Organization, COPD affects nearly 210 million people which is attributed to the increasing population in urban areas across the globe and growing number of tobacco smokers.


The global emphysema market is expected to grow at a CAGR of 6.1% during the forecast period.


FIGURE 1: Global Emphysema Market, by Region, 2016 (%)


 Emphysema Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, and Company Presentation


Segments  


The global emphysema market is segmented on the basis of type, diagnosis, treatment, and end-user.


On the basis of type, the market is segmented into centrilobular and panlobular emphysema.


On the basis of diagnosis, the market is segmented into imaging test, lung function test, and others. The imaging test is further segmented into chest X-ray and CT scan.


On the basis of treatment, the market is segmented into medications, therapy, and surgery. Medications are further segmented into smoking cessation drugs, bronchodilators, inhaled steroids, antibiotics, and leukotriene modifiers. Therapy is further segmented into pulmonary rehabilitation, nutrition therapy, gene therapy, and supplemental oxygen. Surgery is further segmented into lung volume reduction surgery, lung transplant, and bullectomy.


On the basis of end-user, the market is segmented into hospitals and clinics, surgical centers, and others.


Intended Audience



  • Drug Manufacturers

  • Drug Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


Research Methodology


 Emphysema Methodology


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, and Company Presentation


Regional Analysis of the Global Emphysema Market               


The American emphysema market is segmented into two regions, namely, North America and South America. North America, being the largest market, is mainly driven by the increasing use of imaging test and lung function test for the diagnosis of the disease and huge population base diagnosed with COPD. Furthermore, the U.S. is the largest market in North America owing to the presence of large number of market players manufacturing medications for emphysema and increasing awareness about risk factors and cases of the disease. The American Lung Association stated that in the U.S., COPD is the fourth leading cause of deaths. Canada is expected to be the fastest growing market which is driven by the overall increasing demand for diagnostic medical devices with progress in the medical device sector. South America is expected to be the fastest growing market due to technologically advanced devices for diagnosis and the increasing demand for treatment options of respiratory diseases


The European emphysema market exhibits a positive growth with an increasing emphasis on the diagnosis of chronic respiratory conditions such as the COPD and asthma and increasing focus on research and development activities for the treatment of respiratory diseases. Germany and the U.K. are the major contributors to the growth of the market. Additionally, increasing expenditure in healthcare by major countries in Europe also accelerates the growth of the market.


Asia Pacific is expected to be the fastest growing market whose growth is attributed to a huge demand for lung function test and other diagnostic tests and the increasing focus on early diagnosis and treatment of lung diseases. Furthermore, other factors contributing to the growth of the market are lifestyle changes, the influence of western culture among the adults, and addiction to smoking. Additionally, rising environmental pollution and exposure to harmful chemicals also attribute to the growth of the market.


The Middle Eastern and African market for emphysema exhibits a steady rise with an increase in the number of healthcare facilities providing treatment for the chronic condition and the flourishing growth of medical device sector especially the diagnostic devices such as MRI and CT. In the African region, the awareness about COPD is increasing and is fueling the growth of the market.


Key Players in the Global Emphysema Market


Some of the key players in this market are Intrexon Corporation, Pulmonx Inc., Halozyme Therapeutics, Inc., Mariposa Health Limited, PneumRx, Uptake Medical Corporation, Icure Pharmaceuticals, Inc., Pfizer, Inc., BTG International’s, Olympus Corporation, Kamada Limited, Emphasys Medical, Inc. and others.



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

Emphysema is a lung disease characterized by shortness of breath, causing damage to the air sacs in the lungs.

Global Emphysema Market is expected to exhibit a strong 6.1% CAGR over the forecast period from 2020 to 2027.

The growing prevalence of respiratory diseases is the major driver for the Emphysema Market.

The Americas dominate the Global Emphysema Market.

Leading players in the Emphysema Market include Pulmonx Inc., Intrexon Corporation, and Halozyme Therapeutics, among others.